Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara S Oltra

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|November 26, 2020
Insight updating of the molecular hallmarks in ovarian carcinomaAlba Mota, Sara S Oltra, Gema Moreno-Bueno
Cell Cycle (Georgetown, Tex.)|December 1, 2023
Structural and functional insights into GSDMB isoforms complex roles in pathogenesisSara Colomo, David Ros-Pardo, Sara S Oltra, et al.
Scientific Reports|December 1, 2019
miR302a and 122 are deregulated in small extracellular vesicles from ARPE-19 cells cultured with H<sub>2</sub>O<sub>2</sub>Maria Oltra, Lorena Vidal-Gil, Rosa Maisto, et al.
The Biochemical Journal|July 13, 2016
Isoform-specific function of calpains in cell adhesion disruption: studies in postlactational mammary gland and breast cancerLucía Rodríguez-Fernández, Iván Ferrer-Vicens, Concha García, et al.
Cancers|July 2, 2021
Predictive Role of Leptin Receptor (Ob-R) Overexpression in Patients with Early Breast Cancer Receiving Neoadjuvant Systemic TreatmentLaura García-Estévez, Isabel Calvo, Silvia Pérez, et al.
Scientific Reports|October 20, 2019
Acceleration in the DNA methylation age in breast cancer tumours from very young womenSara S Oltra, Maria Peña-Chilet, Kirsty Flower, et al.
Breast Cancer : Basic and Clinical Research|December 14, 2020
miRNA Expression Analysis: Cell Lines HCC1500 and HCC1937 as Models for Breast Cancer in Young Women and the miR-23a as a Poor Prognostic BiomarkerSara S Oltra, Maria Peña-Chilet, Maria T Martinez, et al.
Breast Cancer : Basic and Clinical Research|March 1, 2019
Breast Cancer in Very Young Patients in a Spanish Cohort: Age as an Independent Bad Prognostic IndicatorMaría Teresa Martínez, Sara S Oltra, María Peña-Chilet, et al.
Scientific Reports|September 28, 2018
Methylation deregulation of miRNA promoters identifies miR124-2 as a survival biomarker in Breast Cancer in very young womenSara S Oltra, Maria Peña-Chilet, Victoria Vidal-Tomas, et al.
Cancers|January 8, 2023
RUNAT-BI: A Ruthenium(III) Complex as a Selective Anti-Tumor Drug Candidate against Highly Aggressive Cancer Cell LinesMarta Albanell-Fernández, Sara S Oltra, Marta Orts-Arroyo, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|November 26, 2020
Insight updating of the molecular hallmarks in ovarian carcinomaAlba Mota, Sara S Oltra, Gema Moreno-Bueno
Cell Cycle (Georgetown, Tex.)|December 1, 2023
Structural and functional insights into GSDMB isoforms complex roles in pathogenesisSara Colomo, David Ros-Pardo, Sara S Oltra, et al.
Scientific Reports|December 1, 2019
miR302a and 122 are deregulated in small extracellular vesicles from ARPE-19 cells cultured with H<sub>2</sub>O<sub>2</sub>Maria Oltra, Lorena Vidal-Gil, Rosa Maisto, et al.
The Biochemical Journal|July 13, 2016
Isoform-specific function of calpains in cell adhesion disruption: studies in postlactational mammary gland and breast cancerLucía Rodríguez-Fernández, Iván Ferrer-Vicens, Concha García, et al.
Cancers|July 2, 2021
Predictive Role of Leptin Receptor (Ob-R) Overexpression in Patients with Early Breast Cancer Receiving Neoadjuvant Systemic TreatmentLaura García-Estévez, Isabel Calvo, Silvia Pérez, et al.
Scientific Reports|October 20, 2019
Acceleration in the DNA methylation age in breast cancer tumours from very young womenSara S Oltra, Maria Peña-Chilet, Kirsty Flower, et al.
Breast Cancer : Basic and Clinical Research|December 14, 2020
miRNA Expression Analysis: Cell Lines HCC1500 and HCC1937 as Models for Breast Cancer in Young Women and the miR-23a as a Poor Prognostic BiomarkerSara S Oltra, Maria Peña-Chilet, Maria T Martinez, et al.
Breast Cancer : Basic and Clinical Research|March 1, 2019
Breast Cancer in Very Young Patients in a Spanish Cohort: Age as an Independent Bad Prognostic IndicatorMaría Teresa Martínez, Sara S Oltra, María Peña-Chilet, et al.
Scientific Reports|September 28, 2018
Methylation deregulation of miRNA promoters identifies miR124-2 as a survival biomarker in Breast Cancer in very young womenSara S Oltra, Maria Peña-Chilet, Victoria Vidal-Tomas, et al.
Cancers|January 8, 2023
RUNAT-BI: A Ruthenium(III) Complex as a Selective Anti-Tumor Drug Candidate against Highly Aggressive Cancer Cell LinesMarta Albanell-Fernández, Sara S Oltra, Marta Orts-Arroyo, et al.
Pageof 2